Keywords
Chronic pain, Cognitive behavior therapy, Mental health, Physical health, Suicide, Self-harm
Chronic pain constitutes a major global public health burden, associated with considerable variation in prevalence, disability, quality of life, and mental health outcomes. While cognitive behavioural therapy (CBT) is widely used in the management of chronic pain, its role in addressing mental and physical health symptoms and suicidality in this population remains unclear. This scoping review aims to systematically map the mental and physical health outcomes assessed in CBT interventions for chronic pain, and to highlight what CBT changes and to identify psychological factors that may explain variability in suicidality and self-harm risk across this population.
This scoping review will be conducted in accordance with the Joanna Briggs Institute (JBI) methodology, and findings will be reported following the PRISMA-ScR guidelines. A comprehensive search will be conducted using all relevant electronic databases, including PubMed, Scopus, Embase, and PsycINFO. Studies will be eligible if they include individuals with chronic pain receiving CBT interventions. Data extraction will include study characteristics, participant demographics, and reported mental and physical health outcomes with specific attention to suicidality-related outcomes, including suicidal ideation, self-harm, and suicide attempts. The review will also examine proposed psychological mechanisms underlying CBT intervention effects.
This review will provide the first comprehensive mapping of evidence at the intersection of chronic pain, CBT interventions, and mental and physical health outcomes, with emphasis on suicidality. Findings will be presented using a descriptive summary and accompanied by a narrative synthesis of results.
This review will provide a comprehensive overview of the current literature, identify mechanisms and psychological processes linked to suicide risk, to inform future research directions, including the development of targeted interventions for individuals with chronic pain.
Chronic pain, Cognitive behavior therapy, Mental health, Physical health, Suicide, Self-harm
Chronic pain affects people globally with cross-national variation in prevalence, associated disability and reduced quality of life (Zimmer et al., 2022). Beyond its physical burden, chronic pain has profound psychosocial consequences, including elevated risks of depression, anxiety disorders, hopelessness, and in severe cases, self-harm and suicidality (Tang & Crane, 2006; Calati et al., 2015; Racine, 2018). Evidence also suggests that suicide risk may vary across different chronic pain conditions. Individuals living with conditions such as migraine, fibromyalgia, and neuropathic pain have been shown to higher rates of suicide outcomes as compared to pain free populations (Ilgen et al., 2008; Ratcliffe et al., 2008; Campbell et al., 2015).
Breivik et al. reported that patients with chronic pain have a fourfold higher risk of suicide attempt compared to the general population (Breivik et al., 2014). Similarly, a recent meta-analysis estimated a lifetime prevalence of suicidal ideation at 28.9% and suicide attempts at 10.8% among individuals with chronic pain, with more than one in four reporting suicidal ideations in the preceding two weeks (Kwon & Lee, 2023). Population based research has also shown chronic pain diagnoses to be nearly three times more common among suicide deaths, often alongside psychiatric comorbidities, highlighting the complex vulnerability of this group (DiBlasi et al., 2024).
Despite extensive evidence establishing chronic pain as an independent risk factor for suicide, this association remains poorly integrated into clinical risk prediction frameworks. This gap is further reflected in the design of clinical trials in chronic pain populations. Although outcomes such as pain intensity, disability, depression and anxiety are frequently assessed, suicide risk and suicidality outcomes are rarely included as primary or secondary endpoints. This highlights the disconnect between a known risk factor and its systematic absence in research practice (Forden et al., 2024; Mendes Neto et al., 2025).
While many studies have reported an association between chronic pain and elevated risk of suicidality, it is important to note that not all individuals experiencing persistent pain attempt suicide or engage in self-harm. This variability highlights the complex mechanism with interplay of neurobiological, cognitive, and psychological pathways that may contribute to suicide and self-harm risk in this population (Wiech & Tracey, 2009; Elman et al., 2013). Beyond depression and anxiety disorders, emerging evidence suggests that cognitive, emotional and psychological processes may be central to understanding why some individuals living with chronic pain are at greater risk than others (Kirtley et al., 2020; Themelis et al., 2025).
Chronic pain has been identified across multiple studies as a robust and direct driver of suicidality, mediating its effects both directly as a physical health burden and also through psychological mechanisms to give rise to pain catastrophizing, feelings of hopelessness, entrapment, perceived burdensomeness, loss of meaning in life, social isolation and reduced self-efficacy each of which are recognized as predisposing factors for suicidal thoughts and behaviors (Edwards et al., 2006; Tang et al., 2007; O’Connor, 2011; Racine, 2018; Klonsky et al., 2021). Yet these pathways have rarely been measured together in a structured and systematic way within pain research. Hence, it remains difficult to determine which specific mental and physical health outcomes of the chronic pain experience drive suicide risk, whether independently or in combination. Mapping these outcomes would identify mediating and moderating factors, distinguish subgroups of patients at elevated risk, and test theoretically grounded models of suicidality such as the Interpersonal Theory of Suicide, in which chronic pain may directly amplify both thwarted belongingness and perceived burdensomeness.
Despite increasing recognition of these individual factors, the extent to which these comorbid physical and mental health outcomes independently contribute to, or interact with, psychological mechanistic factors to elevate suicidality in chronic pain populations remains poorly understood. Consequently, this underscores the need for comprehensive understanding of these interconnected factors in chronic pain populations at risk of suicidality and self-harm.
Within chronic pain populations, this interplay also has important implications for diagnostic assessment and treatment. Although non-opioid analgesics such as paracetamol are among the most prescribed pain medications, evidence suggests that opioids, presents an additional concern in the context of suicidality. Opioids are consistently identified among the most employed agents in suicide attempts and deaths, leading to increased risk in individuals with chronic pain (Alothman et al., 2023). This reinforces the critical importance of integrating and prioritising non-pharmacological interventions, which not only address pain management but also reduce dependence on potentially lethal pharmacological agents.
Cognitive Behavioural Therapy (CBT) is well established in the treatment of mood disorders and chronic pain (Ehde et al., 2014; Williams et al., 2012). It offers structured, skills-based strategies and has demonstrated efficacy in reducing pain interference, pain related disability, and psychological distress (Buhrman et al., 2016; Sanabria-Mazo et al., 2023). Recent developments have expanded the scope of CBT intervention delivery. Emphasis is being made on the scalability and maintenance of treatment gains from psychological interventions for chronic pain, particularly with respect to long-term outcomes such as suicidality (Dorfman et al., 2025; Darnall, 2025).
While CBT reliably improves some psychological outcomes, its effects on suicidality in chronic pain population remains underexplored and inconsistently reported (Sanabria-Mazo et al., 2023). To improve the effectiveness of psychotherapeutic approaches for pain and its associated mental and physical health impacts, we need to better understand treatment mechanisms (Burns, 2016). Also, most research has focused on specific pain conditions or on comparative efficacy between CBT and alternative interventions (e.g., mindfulness or acceptance-based approaches), rather than systematically examining suicide-related psychological outcomes across chronic pain populations.
This scoping review aims to address this gap by systematically examining CBT’s effects on broader mental and physical health outcomes such as depression, hopelessness, pain intensity, sleep disturbances and quality of life in chronic pain populations. This review will additionally explore CBT interventions for chronic pain populations in which suicidality or self-harm is present or assessed. We will also search for evidence on how CBT influences suicide risk in chronic pain populations, via exploring mechanisms and characterizing delivery formats, study contexts, and knowledge gaps in the field. By addressing these gaps, this review will lay the groundwork for future trials that integrate suicide prevention within psychological pain management and inform the development of clinical guidelines in this area.
What is known from the existing literature about the use of CBT in chronic pain populations, specifically in relation to mental and physical health outcomes including suicidality and suicide-related outcomes?
The objective of this scoping review is to systematically map and synthesize the existing literature on the role of CBT in chronic pain populations, with a specific focus on mental and physical health outcomes, including suicidality and suicide-related outcomes.
The review will aim to:
1. Identify and describe the scope of existing studies that evaluate CBT among people experiencing chronic pain, including randomized controlled trials (RCT), quasi-experimental, pre-post studies, cohort studies, qualitative studies and secondary analyses of RCT data.
2. Assess the range of outcomes studied, including mental health outcomes [depression, anxiety, including psychological mechanisms (such as catastrophizing, perceived burdensomeness, emotional regulation, hopelessness, defeat/entrapment, psychological distress)] and physical health outcomes (pain intensity, pain duration, sleep disorders, and quality of life) and suicide-related outcomes including suicidal ideation, self-harm, suicide attempts, that may mediate effects on suicidality risk.
3. Review delivery formats and contexts of CBT interventions (e.g., face-to-face, group, digital, blended care) and assess their relevance for populations at elevated risk of suicide and self-harm.
This scoping review will be developed and conducted in accordance with JBI guidance for the conduct of scoping reviews (Peters et al., 2022) and reported following the framework outlined by the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) (Tricco et al., 2018) guidelines to ensure transparency and rigor in the review process.
Inclusion criteria
For the purposes of this review, we will include studies that have chronic pain pre-defined by International Classification of Diseases, 11th Revision (ICD-11) by WHO 2019 as ICD-11 code or earlier as ICD-10 code. (The ICD operationalizes chronic pain that persists or recurs for more than 3 months. It includes seven main categories of chronic pain - chronic primary pain, chronic cancer-related pain, chronic postsurgical or posttraumatic pain, chronic secondary musculoskeletal pain, chronic secondary visceral pain, chronic neuropathic pain, chronic secondary headache or orofacial pain.) (Treede et al., 2019).
Studies will also be screened to include psychological or transdiagnostic factors reported in CBT-based chronic pain studies that may explain changes in mental health and suicidality-related outcomes. Studies with any reported mediators, moderators, or process variables associated with CBT-related changes will be included. Some psychological factors reported can be pain catastrophizing, hopelessness, emotion regulation, perceived burdensomeness/thwarted belongingness, self-efficacy, coping strategies or fear avoidance. Attention will be given to factors that may be relevant to understanding variability in suicidality and self-harm risk among individuals with chronic pain.
Studies that include suicidality, such as suicidal acts, ideation, attempts or plans as defined by the WHO (World Health Organization, 2014). Likewise, studies including self-harm as referred to non-fatal, self-inflicted harm irrespective of intent defined by the National Institute for Health and Care Excellence (NICE 2022) will be included. Study designs such as RCTs, quasi-experimental, pre-post studies, cohort studies, and secondary analyses of RCT data published in English language will be added to the final compilation list for screening and final selection.
Studies published between January 2010, and March 2026 will be included. This timeframe is selected to capture research conducted during a period of conceptual and methodological advancement in both chronic pain and suicidality. From the year 2010, chronic pain began to be recognized as a distinct disease entity rather than a symptom, leading to its revised classification in ICD by WHO 2019 (Treede et al., 2019). This period also saw the emergence and widespread adoption of O’Connor’s theoretical framework of suicidality, the Integrated-Motivational-Volitional Model (O’Connor, 2011). Together, these developments represent advancements relevant to the focus of this review.
Exclusion criteria
Studies not available in English, non-peer-reviewed literature, only review studies, in pediatric population (17 years and under) and studies where CBT is not clearly defined as an intervention will be excluded. Also, studies that do not report suicide-related or physical/psychological mechanisms will be excluded.
The articles will be screened in accordance with the Population, Concept, Context, and Outcome PCC(O) strategy that is explained in Table 1.
Electronic databases such as PubMed, Scopus, Embase, and PsycINFO will be searched. Additionally, references for included studies will be reviewed.
A comprehensive search strategy will be implemented across the following electronic databases: PubMed, Scopus, Embase, and PsycINFO. Search terms were developed to reflect ICD-11 chronic pain categories using corresponding MeSH terms and free-text keywords. Search strategies were designed to maximize sensitivity and were not restricted by outcomes. Outcomes of interest (e.g., pain catastrophizing, psychological flexibility, depression, anxiety) were applied during the screening and data extraction stages. A detailed search summary of one large database PubMed can be found here in Open Science Framework registration 10.17605/OSF.IO/GDV4J
All identified records will be imported into Rayyan (https://www.rayyan.ai/) for screening and de-duplication. One reviewer will independently screen the titles and abstracts against the inclusion criteria. Full-text articles will be retrieved for studies that meet the inclusion criteria or where there is uncertainty. Any discrepancies found will be resolved through discussion with the supervisors, and a second reviewer will be consulted if consensus cannot be reached.
Data extraction will be performed on all studies included after full-text screening. This will be completed by one reviewer using Microsoft Excel; the extracted data will then be checked against the original record by an independent second reviewer. Data extraction form will be developed and pilot-tested on a subset of included studies. Data to be extracted includes study characteristics, population details, intervention specifics, mechanism specific outcomes measured, and key findings as summarised in data extraction sheet in Table 2.
A narrative synthesis will be performed to summarize the findings. Quantitative data will be presented in tabular form, while qualitative data, if any found, will be thematically analyzed. We will use the PRISMA-ScR (Tricco et al., 2018) checklist to ensure comprehensive reporting. The methodological quality of the selected studies will be assessed following JBI Guidelines (Peters et al., 2022) and presented descriptively. Any potential limitations related to the breadth of the search and potential gaps in the available evidence will also be acknowledged and reported.
The methods outlined in this protocol are rigorous and comprehensive, ensuring a thorough mapping of the literature on the role of CBT interventions for chronic pain. By adhering to established guidelines, this review aims to provide a reliable foundation for understanding the current state of research and identifying areas for future investigation.
This scoping review addresses the growing recognition of chronic pain as a distinct clinical condition and its established association with increased risk of suicidality and self-harm. While CBT is widely used in the management of chronic pain, its role in addressing suicidal ideation and behaviours within this population remains unclear. In addition, limited attention has been paid to the underlying mechanisms through which CBT may influence both physical and mental health outcomes. By systematically mapping the existing evidence, this review will provide a comprehensive overview of the current literature, identify mechanisms and psychological processes linked to suicide risk, to inform future research directions, including the development of targeted interventions for individuals with chronic pain.
No data are associated with this article.
Extended data associated with this article are available on OSF, under the project on Open Science Framework repository (OSF) titled, “The mental and physical health impact of Cognitive Behavioural Therapy among people with chronic pain: a scoping review protocol”, https://doi.org/10.17605/OSF.IO/Q6NHA(Akhtar et al., 2026).
This project contains the following underlying data:
Data is available under the terms of the CC-By Attribution 4.0 International.
Relevant study materials such as data extraction file, search strategy and any supplementary documentation that will be developed during the study will be deposited in this repository.
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Not applicable
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: My areas of research have been mental health interventions in primary care settings, epidemiology of chronic pain conditions, and evaluation of self-management interventions for chronic pain.
Alongside their report, reviewers assign a status to the article:
| Invited Reviewers | |
|---|---|
| 1 | |
|
Version 1 20 May 26 |
read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Register with HRB Open Research
Already registered? Sign in
Submission to HRB Open Research is open to all HRB grantholders or people working on a HRB-funded/co-funded grant on or since 1 January 2017. Sign up for information about developments, publishing and publications from HRB Open Research.
We'll keep you updated on any major new updates to HRB Open Research
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)